FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tessa ten Hove

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Living Beings

Physiology

Up-Regulation

Procedures

Flow Cytometry

Co-author Network

Publications

TOP 3
Tessa ten Hove; F The Olle; Marloes Berkhout; Joost P Bruggeman; Florry A Vyth-Dreese; J F M Slors; Sander J H van Deventer; Anje A Te Velde
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Michalda S Dunker; Tessa ten Hove; Willem A Bemelman; J F M Slors; Dirk J Gouma; Sander J H van Deventer
Interleukin-6, C-reactive protein, and expression of human leukocyte antigen-DR on peripheral blood mononuclear cells in patients after laparoscopic vs. conventional bowel resection: a randomized study.
Bernt van den Blink; Tessa ten Hove; Gijs R van den Brink; Maikel Peppelenbosch; Sander J H van Deventer
From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tessa ten Hove (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Tessa ten Hove; F The Olle; Marloes Berkhout; Joost P Bruggeman; Florry A Vyth-Dreese; J F M Slors; Sander J H van Deventer; Anje A Te Velde
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Journal of leukocyte biology 2004;75(6):1010-5.
2003: Michalda S Dunker; Tessa ten Hove; Willem A Bemelman; J F M Slors; Dirk J Gouma; Sander J H van Deventer
Interleukin-6, C-reactive protein, and expression of human leukocyte antigen-DR on peripheral blood mononuclear cells in patients after laparoscopic vs. conventional bowel resection: a randomized study.
Diseases of the colon and rectum 2003;46(9):1238-44.
2002: Bernt van den Blink; Tessa ten Hove; Gijs R van den Brink; Maikel Peppelenbosch; Sander J H van Deventer
From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease.
Annals of the New York Academy of Sciences 2002;973():349-58.
2002: Tessa ten Hove; Paul Drillenburg; Jan Wijnholds; Anje A Te Velde; Sander J H van Deventer
Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis.
Digestive diseases and sciences 2002;47(9):2056-63.
2002: Anne Corbaz; Tessa ten Hove; Suzanne Herren; Pierre Graber; Boris Schwartsburd; Ilana Belzer; Jillian Harrison; Thomas Plitz; Marie H Kosco-Vilbois; Soo-Hyun Kim; Charles A Dinarello; Daniela Novick; Sander J H van Deventer; Yolande Chvatchko
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(7):3608-16.
2002: Tessa ten Hove; Bernt van den Blink; I Pronk; Paul Drillenburg; Maikel Peppelenbosch; Sander J H van Deventer
Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.
Gut 2002;50(4):507-12.
2001: Tessa ten Hove; Anne Corbaz; H Amitai; S Aloni; Ilana Belzer; Pierre Graber; Paul Drillenburg; Sander J H van Deventer; Yolande Chvatchko; Anje A Te Velde
Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice.
Gastroenterology 2001;121(6):1372-9.
2001: Y H Yuan; Tessa ten Hove; F O The; J F M Slors; Sander J H van Deventer; Anje A Te Velde
Chemokine receptor CXCR3 expression in inflammatory bowel disease.
Inflammatory bowel diseases 2001;7(4):281-6.
2001: Annelies Verbon; Pascale E P Dekkers; Tessa ten Hove; C Erik Hack; John P Pribble; Terence Turner; Sonia Souza; Tim Axtelle; Frans J Hoek; Sander J H van Deventer; Tom van der Poll
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3599-605.
2001: Bernt van den Blink; Nicole P Juffermans; Tessa ten Hove; Marcus Schultz; Sander J H van Deventer; Tom van der Poll; Maikel Peppelenbosch
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):582-7.
2000: Pascale E P Dekkers; Tessa ten Hove; Fanny N Lauw; HR Koene; P Lumley; Sander J H van Deventer; Tom van der Poll
The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans.
Infection and immunity 2000;68(5):3036-9.
2000: Pascale E P Dekkers; Tessa ten Hove; Anje A Te Velde; Sander J H van Deventer; Tom van der Poll
Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.
Infection and immunity 2000;68(4):2156-60.
2000: Pascale E P Dekkers; Nicole P Juffermans; Tessa ten Hove; Evert de Jonge; Sander J H van Deventer; Tom van der Poll
Endotoxin down-regulates monocyte and granulocyte interleukin-6 receptors without influencing gp130 expression in humans.
The Journal of infectious diseases 2000;181(3):1055-61.
2000: Fanny N Lauw; Tessa ten Hove; Pascale E P Dekkers; Evert de Jonge; Sander J H van Deventer; Tom van der Poll
Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.
Infection and immunity 2000;68(3):1014-8.
1999: Pascale E P Dekkers; Fanny N Lauw; Tessa ten Hove; Anje A Te Velde; P Lumley; D Becherer; Sander J H van Deventer; Tom van der Poll
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemia.
Blood 1999;94(7):2252-8.
1999: Maikel Peppelenbosch; M Desmedt; Tessa ten Hove; Sander J H van Deventer; Johan Grooten
Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways.
Blood 1999;93(11):4011-8.